Development and Use of Ambulatory Adverse Event Trigger Tools (Text Version) Slide presentation from the AHRQ 2010 conference. On September 29, 2010, Amy Rosen made this presentation at the 2010 Annual Conference. Select to access the PowerPoint® presentation (190 KB). Free PowerPoint® Viewer (Plugin Software Help).Slide 1Development and Use of Ambulatory Adverse Event Trigger ToolsAmy K. Rosen, PhDAHRQ ConferenceSept. 29, 2010Boston University School of Public Health, Boston, MA,VA Center for Organization, Leadership and Management Research (COLMR), Boston MAakrosen@bu.eduSlide 2AcknowledgementsSponsored by AHRQ Contract No. HHSA290200600012, Task Order Officer: Amy Helwig, MD.PI Amy Rosen, PhDCo-PI Jonathan Nebeker, MD, MSCo-Investigators: Stephan Gaehde, MDHaytham Kaafarani, MD, MPHBrenna Long, MAHillary Mull, MPPBrian Nordberg, BSSteve Pickard, MSPeter Rivard, PhDLucy Savitz, PhD, MBAChris Shanahan, MD, MPHStephanie Shimada, PhDSlide 3Project Goal and SettingsGoal: Develop adverse event (AE) triggers for the outpatient setting: Outpatient surgery AEs.Outpatient diagnostic testing and loss to follow-up AEs.Outpatient adverse drug events (ADEs)Three sites for patient data: Boston Medical Center (BMC)Intermountain HealthcareWestern region of the Veterans Health Administration (VA)Slide 4BackgroundTrigger tool: A screen applied to healthcare data that triggers review of a patient record for a potential adverse event.Trigger: An algorithm that uses electronic medical record data to identify patterns consistent with a possible adverse event.Example: combination of a lab value threshold and an active prescription.AE specific trigger: A trigger intended to identify a specific adverse event.Slide 5MethodsMethodsStepsDevelop TriggersClinicians review literature to develop potential outpatient AE triggersReview these triggers with focus groupsHold Delphi process to refine trigger logic, develop new triggersEstablish list of outpatient AE triggers to testMerge DataObtain de-identified data extracts from each siteMerge variables from each site into trigger project databaseIterative process of checking data quality and obtaining new data extractsProgram triggers and perform chart classificationProgram trigger algorithms to run on data in project database and flag casesIterative process of running trigger and checking data qualityBuild mock electronic medical record (EMR) to interface with project databasePerform chart classificationAnalyze trigger performanceCalculate positive predictive value (PPV) and 95% confidence intervals for each triggerImage: There is a flowchart next to the above table. The steps of the flowchart are: List of triggers → Program trigger algorithms → Trigger-flagged cases → Chart review. In addition, the Project database has arrows to both Program trigger algorithms and Chart review.Slide 6Methods: Outpatient Surgery TriggersSample: N=17,492 ambulatory surgeries from three institutions in CY05.Sampling for chart review: 17 trigger-flagged cases from each site to the extent the data were available.Definition of AE: NSQIP AEs: Surgeries with an event that meets the National Surgical Quality Improvement Program criteria for an AE (e.g., postoperative urinary tract infection).Other AE: Surgery with an AE determined by nurse clinical judgment (e.g., postoperative iatrogenic injury).Analysis: PPV = number of patients with AE/number of positive triggersSlide 7Methods: Loss to Follow-up TriggerDefinition of AE: Failure to follow-up on abnormal fecal occult blood test (FOBT) results, which could potentially lead to a failure to detect colorectal cancer or pre-cancerous growths in a timely manner. In the event a patient has a positive FOBT, the standard of care is a colonoscopy within 2 months.We designed the trigger to exclude bleeding that might potentially be due to a recently diagnosed ulcer or GI surgery.Analysis: PPV was calculated for cases without a colonoscopy and cases missing an appropriate colonoscopy.Slide 8Methods: Focus GroupsWe conducted 90-minute focus group and multiple 30-45 minute interviews at each of the sites between October and December 2009.Participants were frontline staff, middle managers and executives including: Physicians (medicine and surgery)NursesInformatics and information systems expertsPharmacistsQuality and patient safety expertsSlide 9Results: Outpatient Surgery TriggersTrigger NameTrigger RuleCases FlaggedN (%)Flagged Cases Sampled for ReviewPPV for NSQIP AEs (95% CI)PPV for Any AE (95% CI)Emergency Department (ED)Outpatient surgery AND subsequent ED visit ≤ 21 days519(3%)10012%(6-20%)49%(39-59%)AdmissionOutpatient surgery AND admission to hospital ≤ 30 days3,8460(22%5112%(4-24%)41%(26-56%)ProcedureOutpatient surgery AND procedure (interventional radiological OR urological OR cardiac OR gastroenterological) OR re-operation ≤ 30 days1,132(7%)516%(1-16%)24%(13-37%)Length of Stay (LOS)Outpatient surgery AND subsequent admission with length of stay > 24 hours1,002(7%)516%(1-16%)25%(14-40%)Slide 10Results: Outpatient Surgery TriggersTrigger NameTrigger RuleCases FlaggedN (%)Flagged Cases Sampled for ReviewPPV for NSQIP AEs (95% CI)PPV for Any AE (95% CI)Pulmonary Embolism (PE)/ Deep Vein Thrombosis (DVT)Outpatient surgery AND ICD-9-CM code for DVT OR PE ≤ 30 days189(1%)15058%(50-66%)65%(56-72%)PE/DVT: 52%(43-60%)Surgical Site Infection (SSI) 1Outpatient surgery AND antibiotics started or continued > 24 hoursOR wound debridement CPT code within 5-30 days1,408(8%)51SSI: 4%(0.5-13%)18%(8-28%)HematocritOutpatient surgery AND hematocrit check ≤ 14 days and hematocrit drop > 6 units from preoperative baseline ≤ 1 year before the index event451(3%)NANA100%Slide 11 Results: Loss to Follow-up TriggerSample: N=995 cases with positive FOBT tests in CY05 from one institutionTrigger Rule# trigger-positive2 monthspost FOBTCriteriaNumbermeetingcriteria at6 monthsPPV(95% CI)Positive FOBTAND (serum Fe<60 mcg/dL OR plasma/serum ferritin<40 ng/mL OR MCV<80 fL OR HCT<36%)AND age greater than 21AND no colonoscopy at two months afterFOBTAND no (diagnosis code for upper GI ulcerOR CPT code for GI surgery) ≤1 month prior85Number with no colonoscopy5666%(5-76%)Number with no colonoscopy AND with no clinical reason why not2934%(24-45%)Number with no colonoscopy AND with no clinical reason AND no documented refusal2226%(17-37%)Slide 12Results: Focus Group/InterviewsTriggers ranked from highest to lowest likelihood of adoption.Image: A bar chart displays the following information: Adoption LikelyAdoption UnclearAdoption UnlikelyPE/DVT80%20%-Admission67%23%-Procedure67%25%8%Surgical Site Infection56%44%-Length of Stay44%56%-ED Visits44%36%20%Hematocrit32%45%23%FOBT32%48%20%Slide 13Results: Focus Group/InterviewsTriggers ranked from highest to lowest perceived ease of implementation.Image: A bar chart displays the following information: Implementation StraightforwardImplementation UnclearImplementation DifficultProcedure84%8%8%PE/DVT74%26%-ED Visits70%30%8%Admission74%18%8%Length of Stay74%18%8%Hematocrit58%28%14%Surgical Site Infection20%60%20%FOBT34%58%8%Slide 14SummaryThe set of surgical triggers (excluding 'Hematocrit') required review of 454 cases and detected at least one AE in 204 ambulatory surgeries (PPV for any AE=45%). Many surgeries had more than one AE detected.Triggers best suited for adoption: Admission: flag rate=22%; PPV for detection of any AE=41%; popular in focus groups.PE/DVT: flag rate=1%; PPV for detection of any AE=65%; very popular in focus groups.FOBT: flag rate=8%; PPV for detection of any cases without colonoscopy after 6 months=66%; very popular in focus groupsSlide 15ImplicationsTriggers may have potential to screen for outpatient AEs using a focused sample of cases.Triggers could complement existing screening programs used to detect AEs.Potential for real-time AE detection, particularly with electronic medical records.Slide 16Dissemination to DateRosen AK & Nebeker JR, Use of Trigger Tools to Identify Risks and Hazards to Patient Safety, Sept. 2010. Speakers, AHRQ 2010 Annual Conference, Bethesda, MD.Long BL, Pickard S, Mull HJ, Hoffman JM, Rosen AK & Nebeker JN, Reliability of AHRQ Harm Scale Used with Explicit Criteria in Retrospective ADE Classification, Sept. 2010. Poster, AHRQ 2010 Annual Conference, Bethesda, MD.Shimada S, Mull HJ, Kaafarani H, Rosen AK, Nebeker JR, Nordberg B, Pickard S & Singh H. Development and Assessment of a Trigger Tool to Detect Patients with Positive Fecal Occult Blood Test (FOBT) Results Who Are Lost to Follow-Up. Accepted poster, AMIA 2010 National Symposium, Nov 2010, Washington, DC.Kaafarani H, Rosen AK, Nebeker JR, Shimada SL, Mull HJ, Rivard PE, Savitz L, Helwig A, Shin MH & Itani KMF. Development of Trigger Tools for Surveillance of Adverse Events in Ambulatory Surgery, 2010. Quality and Safety in Health Care. [E-pub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/20513790Mull H & Nebeker JR, Informatics Tools for the Development of Action-Oriented Adverse Drug Event Triggers, 2008. AMIA Annual Symposium Proceedings. Nov 6:505-9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655939/Mull HJ, Nordberg B, Nebeker JR, Using Electronic Medical Records Data for Health Services Research, Case Study: Development and Use of Ambulatory Adverse Event Trigger Tools. Speaker, AcademyHealth Annual Research Meeting, June 2010, Boston, MA.Slide 17Dissemination to Date (cont'd)Shimada S, Rivard P, Nebeker JR, Savitz L, Shanahan C, Gaehde S & Rosen AK. Priorities & Preferences of Potential Ambulatory Trigger Tool Users. Speaker, AcademyHealth Annual Research Meeting, June 2009, Chicago, IL.Kaafarani H, Rosen AK, Nebeker JR, Shimada SL, Rivard PE, Mull HJ, Long B, Shin MH, Savitz L & Itani KMF. Developing Trigger Tools for Surveillance of Adverse Events in Same-Day Surgery: A Literature-Based, End-User Inspired and Expert-Evaluated Methodology, Sept 2009. Poster, AHRQ 2009 Annual Meeting, Bethesda, MD.Mull HJ, Shimada S, Nebeker JR & Rosen AK, A Review of the Trigger Literature: Adverse Events Targeted and Gaps in Detection, June 2008. Proceedings of the Trigger and TIDS Expert Meeting, Agency for Healthcare Research and Quality, Bethesda, MD. http://www.ahrq.gov/qual/triggers/triggers1.htmNebeker JR, Stoddard GJ & Rosen AK, Considering Sensitivity and Positive Predictive Value in Comparing the Performance of Triggers Systems for Iatrogenic Adverse Events, Proceedings of the Trigger and TIDS Expert Meeting, Agency for Healthcare Research and Quality, June 2008. Bethesda, MD. http://www.ahrq.gov/qual/triggers/triggers2.htmShimada S, Rivard PE, Mull HJ, Nebeker JR & Rosen AK, Triggers and Targeted Injury Detection Systems: Aiming for the Right Target With the Appropriate Tool, June 2008. Proceedings of the Trigger and TIDS Expert Meeting, Agency for Healthcare Research and Quality, Bethesda, MD. http://www.ahrq.gov/qual/triggers/triggers3.htm Current as of December 2010 Internet Citation: Development and Use of Ambulatory Adverse Event Trigger Tools (Text Version). December 2010. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/news/events/conference/2010/rosen/index.html